More on NTLA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+13.0% Growth)
- Ratings (6.6 Score)
- Holders

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Intellia Therapeutics (NQ:NTLA)
Delayed: 12.69 -0.04 (0.31%)
Prev. Close $12.73  
Open$12.52 
52 Wk High$30.40 
52 Wk Low$11.86 
Day High$12.81 
Day Low$12.34 
P/E N/A  
EPS$0.00 
Volume2,183,959 

Friends, Peers and Foes (?): CRSP, BEAM, EDIT, ANVS, ALNY (more...)

Aug 25, 2026 04:14 AM Intellia Therapeutics (NTLA) Reiterated at Market Outperform by Citizens Before ESC Congress
Aug 24, 2026 04:05 PM Form 4 Intellia Therapeutics, For: Aug 20 Filed by: LEONARD JOHN M
Aug 20, 2026 04:04 PM Form 144 Intellia Therapeutics, Filed by: LEONARD JOHN M
Aug 7, 2026 04:01 PM Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 7, 2026 09:55 AM Form SCHEDULE 13G Intellia Therapeutics, Filed by: STATE STREET CORP
Aug 6, 2026 04:17 PM Evercore ISI Upgrades Intellia Therapeutics (NTLA) to Outperform
Aug 6, 2026 04:08 PM Form 10-Q Intellia Therapeutics, For: Jun 30
Aug 6, 2026 12:55 PM Intellia Therapeutics (NTLA) PT Lowered to $49 at Jefferies
Aug 6, 2026 07:45 AM Form 8-K Intellia Therapeutics, For: Aug 06
Aug 6, 2026 07:24 AM Intellia Therapeutics (NTLA) Reports In-Line Q2 EPS
View All Articles

Entities mentioned with NTLA

View All Entities